je.st
news
Arena- Belviq Sales Continue To Under-Perform And Underwhelm
2016-02-17 05:30:31| Biotech - Topix.net
Arena saw U.S. sales of Belviq continue to under-perform levels needed to impress the street this past week. Sales are 12% off of the pace established in Q4, and are down a stunning 22% from the levels we were seeing just a year ago.
Tags: sales
continue
arena
underperform
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||